Table of contents

Butter and Salt Builds Job Portal for Ukrainian Refugees

Butter and Salt

Many industrial companies are looking for programmers, designers, developers and other technically trained employees. On the other hand, many well-trained refugees from Ukraine come to Germany and are allowed to enter the job market here directly. Through the new job portal tech-jobs-4-ukrainians.de, it should be made as easy as possible for Ukrainian refugees to be approached by German companies and thus achieve a win-win situation for both sides.

“In our portal, Ukrainians who are looking for a job in technical fields can create a profile. Companies looking for skilled workers can view these profiles. If there is interest in making contact or getting to know each other regarding a possible cooperation, the companies can contact the profile holders,” Florian Schildein, Managing Director of Butter and Salt GmbH, explains the principle of tech-jobs-4-ukrainians.de. Many customers of Butter and Salt GmbH are permanently looking for new skilled personnel. “In some cases, companies have been looking for programmers and similar employees for years. Familiar application processes no longer work here, because there are simply no more free skilled workers on the job market. For many managers, it no longer matters whether an employee speaks German or English. Therefore, we have to turn the search process around. That means companies have to actively approach possible candidates,” Schildein looks back on his own personnel search.

tech-jobs-4-ukrainians.de is a free service for all participants that the team of Butter and Salt has built up over the last few weeks. The costs for this, as well as for the marketing, are and were completely covered by the B2B marketing specialist from Berlin. For Schildein, this is a matter of course: “As an entrepreneur, I am responsible for my company, my employees, my customers and suppliers or partners. But I also have a social responsibility. And if I can do something good with what I do every day, then it is my duty as an entrepreneur to do so within the scope of my possibilities.” The job portal went online after Easter and will now gradually fill up with candidates. The first companies are already using the platform to find suitable candidates.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version